Evaluation of cytokine profiles in rheumatoid arthritis patients with clinically active disease and normal inflammatory indices

Asha M. Alex, Harlan Sayles, Ted R Mikuls, Gail S. Kerr

Research output: Contribution to journalArticle

Abstract

Objective: To assess the potential utility of a cytokine measurement in rheumatoid arthritis (RA) patients with active joint disease but normal acute phase reactants (APR). Methods: RA patients in a longitudinal observational registry with available cytokine array data were included. Patients were categorized based on agreement/disagreement of physical examination and APR measurements: concordant high (CH) [high tender and/or swollen joint counts (TJC + SJC > 3) and APR (ESR ≥ 28 mm/h + CRP ≥ 1.5 mg/L)]; concordant low (CL) [TJC + SJC ≤ 3 and normal APR]. Discordant (D) [TJC + SJC > 3 and normal APR] patients were stratified into low, medium, and high-disease activity (DL, DM, DH). Weighted-average and log-transformed cytokine scores were calculated based on results of a cytokine array. Chi-square tests compared categorical variables by concordance status; t tests, Wilcoxon rank-sum tests, ANOVA models, and ordinary least squares (OLS) regressions were used to compare continuous measures. Results: RA patients (n = 1467) were predominantly male (91%). Compared to CH patients (n = 174), D (n = 434) were younger, less frequently seropositive, with lower TJC, SJC, and DAS28-3v scores (p < 0.001). Cytokine scores for DL, DM, and DH groups were lower than CH patients (p < 0.001) and did not differ between DL, DM, and DH subgroups and were similar to CL (n = 356) patients. In multivariable analyses including CH and D patients, log-cytokine score was associated with higher DAS28-3v scores (p = 0.029). In multivariable analyses including CL patients, concordance status (p = 0.011) and ACPA (p = 0.013) were predictors of higher log cytokine score. Conclusion: In this study, cytokine scores did not identify active joint disease in RA patients with normal APR.

Original languageEnglish (US)
Pages (from-to)1075-1081
Number of pages7
JournalClinical Rheumatology
Volume38
Issue number4
DOIs
StatePublished - Apr 2 2019

Fingerprint

Rheumatoid Arthritis
Cytokines
Acute-Phase Proteins
Joint Diseases
Nonparametric Statistics
Chi-Square Distribution
Least-Squares Analysis
Physical Examination
Registries
Analysis of Variance
Joints

Keywords

  • Biomarkers
  • Cytokine profiles
  • Disease activity
  • Rheumatoid arthritis

ASJC Scopus subject areas

  • Rheumatology

Cite this

Evaluation of cytokine profiles in rheumatoid arthritis patients with clinically active disease and normal inflammatory indices. / Alex, Asha M.; Sayles, Harlan; Mikuls, Ted R; Kerr, Gail S.

In: Clinical Rheumatology, Vol. 38, No. 4, 02.04.2019, p. 1075-1081.

Research output: Contribution to journalArticle

@article{3549e8057a814d0a8f6171eb0659c9bc,
title = "Evaluation of cytokine profiles in rheumatoid arthritis patients with clinically active disease and normal inflammatory indices",
abstract = "Objective: To assess the potential utility of a cytokine measurement in rheumatoid arthritis (RA) patients with active joint disease but normal acute phase reactants (APR). Methods: RA patients in a longitudinal observational registry with available cytokine array data were included. Patients were categorized based on agreement/disagreement of physical examination and APR measurements: concordant high (CH) [high tender and/or swollen joint counts (TJC + SJC > 3) and APR (ESR ≥ 28 mm/h + CRP ≥ 1.5 mg/L)]; concordant low (CL) [TJC + SJC ≤ 3 and normal APR]. Discordant (D) [TJC + SJC > 3 and normal APR] patients were stratified into low, medium, and high-disease activity (DL, DM, DH). Weighted-average and log-transformed cytokine scores were calculated based on results of a cytokine array. Chi-square tests compared categorical variables by concordance status; t tests, Wilcoxon rank-sum tests, ANOVA models, and ordinary least squares (OLS) regressions were used to compare continuous measures. Results: RA patients (n = 1467) were predominantly male (91{\%}). Compared to CH patients (n = 174), D (n = 434) were younger, less frequently seropositive, with lower TJC, SJC, and DAS28-3v scores (p < 0.001). Cytokine scores for DL, DM, and DH groups were lower than CH patients (p < 0.001) and did not differ between DL, DM, and DH subgroups and were similar to CL (n = 356) patients. In multivariable analyses including CH and D patients, log-cytokine score was associated with higher DAS28-3v scores (p = 0.029). In multivariable analyses including CL patients, concordance status (p = 0.011) and ACPA (p = 0.013) were predictors of higher log cytokine score. Conclusion: In this study, cytokine scores did not identify active joint disease in RA patients with normal APR.",
keywords = "Biomarkers, Cytokine profiles, Disease activity, Rheumatoid arthritis",
author = "Alex, {Asha M.} and Harlan Sayles and Mikuls, {Ted R} and Kerr, {Gail S.}",
year = "2019",
month = "4",
day = "2",
doi = "10.1007/s10067-018-4379-5",
language = "English (US)",
volume = "38",
pages = "1075--1081",
journal = "Clinical Rheumatology",
issn = "0770-3198",
publisher = "Springer London",
number = "4",

}

TY - JOUR

T1 - Evaluation of cytokine profiles in rheumatoid arthritis patients with clinically active disease and normal inflammatory indices

AU - Alex, Asha M.

AU - Sayles, Harlan

AU - Mikuls, Ted R

AU - Kerr, Gail S.

PY - 2019/4/2

Y1 - 2019/4/2

N2 - Objective: To assess the potential utility of a cytokine measurement in rheumatoid arthritis (RA) patients with active joint disease but normal acute phase reactants (APR). Methods: RA patients in a longitudinal observational registry with available cytokine array data were included. Patients were categorized based on agreement/disagreement of physical examination and APR measurements: concordant high (CH) [high tender and/or swollen joint counts (TJC + SJC > 3) and APR (ESR ≥ 28 mm/h + CRP ≥ 1.5 mg/L)]; concordant low (CL) [TJC + SJC ≤ 3 and normal APR]. Discordant (D) [TJC + SJC > 3 and normal APR] patients were stratified into low, medium, and high-disease activity (DL, DM, DH). Weighted-average and log-transformed cytokine scores were calculated based on results of a cytokine array. Chi-square tests compared categorical variables by concordance status; t tests, Wilcoxon rank-sum tests, ANOVA models, and ordinary least squares (OLS) regressions were used to compare continuous measures. Results: RA patients (n = 1467) were predominantly male (91%). Compared to CH patients (n = 174), D (n = 434) were younger, less frequently seropositive, with lower TJC, SJC, and DAS28-3v scores (p < 0.001). Cytokine scores for DL, DM, and DH groups were lower than CH patients (p < 0.001) and did not differ between DL, DM, and DH subgroups and were similar to CL (n = 356) patients. In multivariable analyses including CH and D patients, log-cytokine score was associated with higher DAS28-3v scores (p = 0.029). In multivariable analyses including CL patients, concordance status (p = 0.011) and ACPA (p = 0.013) were predictors of higher log cytokine score. Conclusion: In this study, cytokine scores did not identify active joint disease in RA patients with normal APR.

AB - Objective: To assess the potential utility of a cytokine measurement in rheumatoid arthritis (RA) patients with active joint disease but normal acute phase reactants (APR). Methods: RA patients in a longitudinal observational registry with available cytokine array data were included. Patients were categorized based on agreement/disagreement of physical examination and APR measurements: concordant high (CH) [high tender and/or swollen joint counts (TJC + SJC > 3) and APR (ESR ≥ 28 mm/h + CRP ≥ 1.5 mg/L)]; concordant low (CL) [TJC + SJC ≤ 3 and normal APR]. Discordant (D) [TJC + SJC > 3 and normal APR] patients were stratified into low, medium, and high-disease activity (DL, DM, DH). Weighted-average and log-transformed cytokine scores were calculated based on results of a cytokine array. Chi-square tests compared categorical variables by concordance status; t tests, Wilcoxon rank-sum tests, ANOVA models, and ordinary least squares (OLS) regressions were used to compare continuous measures. Results: RA patients (n = 1467) were predominantly male (91%). Compared to CH patients (n = 174), D (n = 434) were younger, less frequently seropositive, with lower TJC, SJC, and DAS28-3v scores (p < 0.001). Cytokine scores for DL, DM, and DH groups were lower than CH patients (p < 0.001) and did not differ between DL, DM, and DH subgroups and were similar to CL (n = 356) patients. In multivariable analyses including CH and D patients, log-cytokine score was associated with higher DAS28-3v scores (p = 0.029). In multivariable analyses including CL patients, concordance status (p = 0.011) and ACPA (p = 0.013) were predictors of higher log cytokine score. Conclusion: In this study, cytokine scores did not identify active joint disease in RA patients with normal APR.

KW - Biomarkers

KW - Cytokine profiles

KW - Disease activity

KW - Rheumatoid arthritis

UR - http://www.scopus.com/inward/record.url?scp=85057584500&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85057584500&partnerID=8YFLogxK

U2 - 10.1007/s10067-018-4379-5

DO - 10.1007/s10067-018-4379-5

M3 - Article

C2 - 30506404

AN - SCOPUS:85057584500

VL - 38

SP - 1075

EP - 1081

JO - Clinical Rheumatology

JF - Clinical Rheumatology

SN - 0770-3198

IS - 4

ER -